A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06565312

Enrollment

Registered

2024-08-21

Start date

2024-05-10

Completion date

2024-07-10

Last updated

2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Health, Vaginal pH

Keywords

Vaginal suppository, Women's Health

Brief summary

This is a virtual single-group clinical trial lasting 8 weeks to evaluate the effects of a probiotic vaginal suppository on vaginal health. Participants will use the Flora Power suppository daily for 5 consecutive days when experiencing common signs of vaginal imbalance. They will complete questionnaires and vaginal pH tests before and after product use.

Interventions

DIETARY_SUPPLEMENTFlora Power Probiotic Vaginal Suppository

The suppository contains Microcrystalline Cellulose, Ascorbic Acid, Vitamin C, Gelatin Capsule, Vaginal Probiotic Blend (Lactobacillus fermentum LF61, Lactobacillus acidophilus LA85, Lactobacillus plantarum Lp90), Magnesium Stearate, and Silicon Dioxide.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Female at birth, aged 18+. * Interested in maintaining a healthy vaginal environment. * Experience common signs of vaginal imbalance (e.g., malodor, irritation). * Willing to avoid other vaginal products and follow study protocol.

Exclusion criteria

* Recent surgeries or invasive treatments. * Use of vaginal health products in the last 12 weeks. * Allergies to product ingredients. * Chronic health conditions impacting participation. * Pregnant, breastfeeding, or trying to conceive. * History of substance abuse or smoking. * Currently participating in another clinical trial.

Design outcomes

Primary

Measure	Time frame	Description
Effect on Vaginal pH and Health	Baseline, Day 6 (24 hours after the last suppository insertion)	Measure the change in vaginal pH levels with a test strip from baseline to 24 hours after the 5-day intervention period.

Secondary

Measure	Time frame	Description
Participant Perception of Vaginal Freshness and Odor	Baseline, Day 2, Day 5	Evaluate participants' perceptions of the vaginal suppository's impact on vaginal freshness and odor, as well as the support of a calm, soothed, and balanced vaginal environment. This outcome measure is assessed with questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026